Effects of curcumin on liver fibrosis induced by cholestasis in mice

doi:10.12047/j.cjap.5796.2019.102

Abstract

Abstract: Objective: To investigate the protective effects of curcumin on bile duct ligation(BDL)-induced liver cholestasis in mice, so as to provide a new treatment strategy for liver fibrosis. Methods: Forty-two healthy adult male BALB/c mice were randomly divided into sham group (n =6), sham+curcumin group (n=6), BDL treatment group (n=10), BDL+curcumin group(n=10), BDL+curcumin+ZnPP group (n=10). Seven days after BDL operation, the sham operation + curcumin group and the BDL+ curcumin group were treated with curcumin at the dose of 30 mg/kg by intraperitoneal injection once a day for 7 days.The mice in BDL+ curcumin +ZnPP group were treated with curcumin (30 mg/kg) and ZnPP (50 μmol/kg) by intraperitoneal injection once a day for 7 days. For the sham group and the BDL group, mice were treated with equal-volume saline daily by intraperitoneal injection. After 14 days of BDL, the plasma and liver tissues were collected, the levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured. The pathological changes of liver tissue and liver fibrosis were observed, and the protein expression of HO-1 in liver tissue was detected. Results: Compared with the sham group, mice in the BDL group had enlarged liver gallbladder and the serum levels of ALT and AST were increased significantly (P＜0.05). Meanwhile, the results of Sirius red staining and qRT-PCR of pro-fibrosis related genes showed collagen deposition in the liver, and immunohistochemistry of macrophages and neutrophils showed inflammatory cell infiltration in the liver. Compared with the BDL group, the serum levels of ALT and AST in the curcumin treatment group were decreased significantly (P＜0.05), collagen deposition and inflammatory cell infiltration were improved, and HO-1 expression was increased (P＜0.05) after curcumin treatement. In the curcumin treatment group, the protective effect of curcumin on liver injury could be reversed by HO-1 active inhibitor ZnPP. Conclusion: Curcumin can improve liver inflammation and fibrosis caused by BDL, and this protective effect is related to the regulation of HO-1 activity by curcumin.

Key words: curcumin, bile duct ligation, heme oxygenase-1, mice, liver fibrosis

WU Chen, QIU Yu-bao, SUN Xue-qian, CHEN Dan, WU Ya-xian, PANG Qing-feng. Effects of curcumin on liver fibrosis induced by cholestasis in mice[J]. CJAP, 2019, 35(5): 468-472.

References

[1] Mendez-Sanchez N, Cruz-Ramon VC, Ramirez-Perez OL, et al. New aspects of lipotoxicity in nonalcoholic steatohepatitis[J]. Int J Mol Sci, 2018, 19(7): 2034-2041.
[2] Beuers U, Trauner M, Jansen P, et al. New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond [J]. J Hepatol, 2015, 62(1): S25-S37.
[3] 郝琴, 王会伟, 俞茜, 等. 姜黄素对大鼠脊髓损伤后后肢功能恢复的作用机制[J]. 中国应用生理学杂志, 2017, 33(5): 441-444.
[4] Farombi EO, Surh YJ. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection[J]. J Biochem Mol Biol, 2006, 39(5): 479-491.
[5] Yang H, Zhao LF, Zhao ZF, et al. Heme oxygenase-1 prevents liver fibrosis in rats by regulating the expression of PPARγ and NF-κB[J]. World J Gastroenterol, 2012, 18(14): 1680-1688.
[6] Malaguarnera L, Madeddu R, Palio E, et al. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients[J]. J Hepatol, 2005, 42(4): 585-591.
[7] Liedtke C, Luedde T, Sauerbruch T, et al. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects[J]. Fibrog Tissue Repair, 2013, 6(1): 19-23.
[8] Lv Y, Lei N, Wang D, et al. Protective effect of curcumin against cytomegalovirus infection in Balb/c mice[J]. Environ Toxicol Pharmacol, 2014, 37(3): 1140-1147.
[9] Li G, Chen JB, Wang C, et al. Curcumin protects against acetaminophen-induced apoptosis in hepatic injury[J]. World J Gastroenterol, 2013, 19(42): 7440-7446.
[10]Weng P, Zhang XT, Sheng Q, et al. Caveolin-1 scaffolding domain peptides enhance anti-inflammatory effect of heme oxygenase-1 through interrupting its interact with caveolin-1[J]. Onco, 2017, 8(25): 40104-40114.
[11]盛琼, 翁平, 张晓彤, 等. 亚甲蓝减轻大鼠离体心脏缺血/再灌注引起的线粒体损伤[J]. 中国病理生理杂志, 2017, 33 (4): 711-716.
[12]Zhang XT, Sun XQ, Wu C, et al. Heme oxygnease-1 induction by methylene blue protects RAW264.7 cells from hydrogen peroxide-induced injury [J]. Adv Biochem Pharmacol, 2018 (148): 265-277.
[13]Tu CT, Yao QY, Xu BL, et al. Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: Modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression[J]. Food Chem Toxicol, 2012, 50(9): 3343-3351.
[14]Eshaghian A, Khodarahmi A, Safari F, et al. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats[J]. Br J Nutr, 2018, 120(4): 393-403.
[15]李晓萍, 李雯, 沈华浩. 抗氧化应激转录因子-Nrf2的研究进展[J]. 中国应用生理学杂志, 2011, 27(6): 1234-1239.
[16]蔡月琴, 张利棕, 王德军, 等. Nrf2及其相关因子在非酒精性脂肪肝炎形成过程中的作用[J]. 中国应用生理学杂志, 2014, 30(5): 465-470.
[17]Dai C, Li B, Zhou Y, et al. Curcumin attenuates quinocetone induced apoptosis and inflammation via the opposite modulation of Nrf2/HO-1 and NF-kB pathway in human hepatocyte L02 cells[J]. Food Chem Toxicol, 2016, 95: 52-63.
[18]Peng X, Dai C, Liu Q, et al. Curcumin attenuates on carbon tetrachloride-induced acute liver injury in mice via Modulation of the Nrf2/HO-1 and TGF-β1/Smad3 pathway.[J]. Mol, 2018, 23(1): 215-219.
[19]叶涛, 刘戌年. 锌原卟啉的研究进展[J]. 国际儿科学杂志, 2002, 29(3): 143-145.